Arizant.com
Press Releases
Media Kit
Join the Team
Certificates and Declarations
Corporate
Donations Policy
Arizant
Code of Conduct
Compliance Program
Certification - California
Clinical Research
Arizant Customers
Contact Information
Email Arizant.com
Support & Downloads
Clinical Research

Are you interested in conducting clinical research?

Thank you for contacting us about your desire to perform research. We have an active research program and are excited about reviewing your protocol. Our Clinical Research Team carefully reviews all proposals, but prior to our evaluation we require that the submission contain the following information. We will notify you promptly concerning our decision about whether to fund your proposal. All proposals become the property of Arizant Healthcare.

Clinical Research Proposal
  • Research hypothesis – Every study must have at least one basic hypothesis that can be tested as described in the methodology and statistical analysis sections.
  • Literature review – A complete review of the relevant source literature must be provided. The review must include a list of citations.
  • Proposed methodology – The proposed plan for testing the research hypothesis must include a detailed protocol. The protocol must describe the proposed study design, randomization scheme, inclusion/exclusion criteria, recruitment plan, data acquisition plan, a list of potential intercurrent or adverse events, and case report forms.
  • HIPAA compliance – The proposal must include a review of the current HIPAA policy at the institution(s) participating in the proposed study. Please include information on whether study sponsors have access to source documents.
  • Statistical analysis plan – A description of how the data will be analyzed, including justification for intention-to-treat analysis or on-treatment analysis must be included. A power analysis, sample size estimate, and a discussion of how type I and II errors will be minimized must be included.
  • Ethics review – A description of potential ethical problems and how they will be avoided. A draft of an Institutional Review Board (IRB) or Independent Ethics Committee (IEC) submission document must be included.
  • Publication plan – The investigator is responsible for producing a final report of the study. Irrespective of the study results, the final report must include a discussion section that explains the research findings.
  • Investigator’s Curriculum Vitae or resume
  • Cost estimate – An itemized breakdown of study costs must be included in the submission package. Are there sources of supplementary funding?
  • Duration estimate – The investigator must include an estimate of the amount of calendar time the study will last.
Please send your submission via the following:

By mail:
Arizant Healthcare Inc.
attn: Al Van Duren, Director of Clinical Affairs
10393 West 70th Street
Eden Prairie, MN 55344

By fax: 952-918-5247, attn: Al Van Duren, Director of Clinical Affairs

By email: avandure@arizant.com
Arizant Healthcare is a proud sponsor of International Infection Prevention Week October 19-25, 2008.
© 2008 Arizant Inc. All rights reserved. / 10393 West 70th Street Eden Prairie, MN 55344
Phone: 952-947-1200 Toll Free: 800-733-7775 Fax: 952-947-1400
Privacy Policy  /  Terms of Use